Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Obstacles to developing vaccines for the Third World.

Robbins A, Freeman P.

Sci Am. 1988 Nov;259(5):126-33.

PMID:
3212439
2.
3.

The United Nations Conference on Population.

Salas RM.

Draper Fund Rep. 1984 Jun;(13):1-3.

PMID:
12339629
4.

Paving the way for the introduction of new vaccines into developing countries.

Chabalgoity JA.

Expert Rev Vaccines. 2005 Apr;4(2):147-50. Review.

PMID:
15889986
5.

WHO expectation and industry goals.

Vandersmissen W.

Vaccine. 2001 Feb 8;19(13-14):1611-5.

PMID:
11166883
6.

Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.

Peny JM, Gleizes O, Covilard JP.

Vaccine. 2005 Aug 31;23(37):4610-8.

PMID:
15979769
7.
8.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
9.

Smoking control strategies in developing countries: report of a WHO Expert Committee.

Masironi R.

World Smoking Health. 1984 Spring;9(1):4-6.

PMID:
12179599
10.

Economic aspects of vaccines and immunizations.

Hinman AR.

C R Acad Sci III. 1999 Nov;322(11):989-94. Review.

PMID:
10646095
11.

[Vaccines: producers in countries of the Southern hemisphere].

Bertrand JJ.

Med Trop (Mars). 2007 Aug;67(4):347-50. French.

PMID:
17926792
12.

Rotavirus vaccines: targeting the developing world.

Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S160-6.

13.

Vaccines, global health and social equity.

Levine MM, Robins-Browne R.

Immunol Cell Biol. 2009 May-Jun;87(4):274-8. doi: 10.1038/icb.2009.15. Review.

PMID:
19308074
14.
15.

Should developing countries be testing grounds for vaccines rejected by the USA?

[No authors listed]

AIDS Anal Afr. 1994 Jul-Aug;4(4):2.

PMID:
12288157
16.

Vaccines as a global imperative--a business perspective.

Stéphenne J.

Health Aff (Millwood). 2011 Jun;30(6):1042-8. doi: 10.1377/hlthaff.2011.0338.

17.

Global perspectives on vaccine financing.

Berman S, Giffin RB.

Expert Rev Vaccines. 2004 Oct;3(5):557-62. Review.

PMID:
15485335
18.

The need for new vaccines.

Taylor K, Nguyen A, Stéphenne J.

Vaccine. 2009 Dec 30;27 Suppl 6:G3-8. doi: 10.1016/j.vaccine.2009.10.014. Review.

PMID:
20006137
19.
20.

The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.

Jadhav S, Datla M, Kreeftenberg H, Hendriks J.

Vaccine. 2008 Mar 20;26(13):1611-5. doi: 10.1016/j.vaccine.2008.01.034. Review.

PMID:
18294742
Items per page

Supplemental Content

Support Center